Search
Tony Keating says he is excited about receiving first regulatory approval for its flagship acute diagnostic product.

ResApp shares spike on EU green light

Shares in digital health company ResApp Health have closed up 33 per cent today to 20 cents, after it received European regulatory approval for its first commercial product – the ResAppDx-EU.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/12/19

1 year TSR5 year TSR
61stResApp Health133%110%
84thConnected IO100%0%
145thSchrole53%-42%
586thProteomics International Laboratories-29%
668 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

20/12/19
$0 Issued
20/12/19
$0 Issued
20/12/19
$0 Issued
Total value as at the date of the transaction
Powered by Morningstar ®

Revenue

104th↑ResApp Health$2.7m
106th↑Proteomics International Laboratories$2.7m
107th↑Schrole$2.7m
109th↑Affinity Energy and Health$2.6m
110th↑Connected IO$2.6m
197 listed industrial companies ranked by revenue.
Powered by Morningstar ®